NCT05580185View on ClinicalTrials.gov

Multicenter, Multinational, Follow-Up Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

CompletedOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

December 8, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

July 30, 2023

Conditions
Respiratory Failure
Interventions
DEVICE

RESPINOR DXT

Blinded, continuous diaphragmatic excursion measurements by DXT will be conducted during the patients' first SBT. The recording shall be initiated 15 minutes prior to the first SBT and will end 15 minutes post SBT.

Trial Locations (8)

13015

Hôpitaux Universitaires de Marseille - AP-HM, Marseille

34090

Centre Hospitalier Universitaire de Montpellier, Montpellier

75571

Hopital Saint-Antoine, Paris

Unknown

CHU Angers, Angers

Centre Hospitalier Saint Joseph Saint Luc, Lyon

CH Saint Joseph Saint Luc, Lyon

Hôpital Universitaire Pitié Salpêtrière, Paris

Oslo University Hospital, Oslo

Sponsors

Collaborators (1)

Link Medical Research AS
All Listed Sponsors
collaborator

Centaur Clinical CRO

UNKNOWN

collaborator

Link Medical Research AS

UNKNOWN

lead

Respinor AS

INDUSTRY